The Effects of Self-monitoring With a Mobile Application in Heart Failure

Completed · Not applicable

Conditions studied: Heart Failure

In brief

In the United States, about 40 percent of heart failure (HF) patients are readmitted within 1-year following their first admission for HF and hospitalization accounts for approximately 70 percent of the costs of HF management. As a result, the management of HF patients is evolving from the traditional model of face-to-face follow-up visits toward a proactive real-time technological model of assisting patients with monitoring and self-management while in the community. The investigators plan to test the impact of a mobile application on clinical outcomes in HF.

Key facts

Study ID

NCT03149510

Run by

University of Michigan

People needed

83

Starts

2017-03-06

Expected to finish

2019-04-30

Last updated by the study team

2020-04-02

Who can join

Age: 45 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• 45 years old or older
• Left ventricular ejection fraction </= 40% or an LVEF > 40% (with left atrial size >40mm or BNP > 200 pg/ml or NT-proBNP > 800 pg/ml)
• Admitted for acutely decompensated heart failure or recently discharged in the past 4 weeks.
• Smartphone (iOS or Android) with home wifi

You may not qualify if…

• Unstable coronary syndrome within 8 weeks (unstable angina, NSTEMI, STEMI)
• Primary valvular heart disease
• Known pericardial disease (Sarcoidosis, amyloidosis, rheumatoid arthritis, lupus)
• Uncorrected thyroid disease
• Advanced renal disease (dialysis or creatinine >4.0 mg/dL)
• End-stage HF (hospice candidate, home milrinone or dobutamine)
• Active cancer
• Pulmonary fibrosis
• Discharge to a setting other than home

Where it is running

• University of Michigan — Ann Arbor, Michigan, United States
• University of Michigan Health System — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.